At Close: 4:00 PM
Adagene Stock Price Graph
Adagene Stock Price Today
Adagene Inc. (ADAG) stock rallied over 19.05% intraday to trade at $1.75 a share on NASDAQ. The stock opened with a loss of -7.91% at $1.35 and touched an intraday high of $1.36, rising 19.05% against the last close of $1.47. The Adagene Inc. in stock market went to a low of $1.34 during the session.
Adagene Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Adagene Stock Price History Chart
Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase I clinical trial for the treatment of advanced metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody, which is in preclinical; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical stage for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a CD20xCD3 POWERbody, which is in preclinical stage for the treatment off-tumor toxicities. The company was incorporated in 2011 and is headquartered in Suzhou, China.
Frequently Asked Questions
What is the current Adagene Inc. (ADAG) stock price?
Adagene Inc. (NASDAQ: ADAG) stock price is $1.75 in the last trading session. During the trading session, ADAG stock reached the peak price of $1.36 while $1.34 was the lowest point it dropped to. The percentage change in ADAG stock occurred in the recent session was 19.05% while the dollar amount for the price change in ADAG stock was $0.28.
ADAG's industry and sector of operation?
The NASDAQ listed ADAG is part of Biotechnology industry that operates in the broader Healthcare sector. Adagene Inc. , a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers.
Who are the executives of ADAG?
Dr. Peter P. Luo Ph.D.
Co-Founder, Chief Executive Officer & Chairman
Ms. Xiaohong She
Senior Vice President & Head of Clinical Operations
Ms. Ami Celeste Knoefler
Vice President of Investor Relations & Corporation Communications
Mr. Man Kin Tam M.B.A.
Chief Financial Officer & Director
How ADAG did perform over past 52-week?
ADAG's closing price is 0.44% higher than its 52-week low of $0.9 where as its distance from 52-week high of $2.1 is -0.65%.
How many employees does ADAG have?
Number of ADAG employees currently stands at N/A. ADAG operates from Building C14, Suzhou, 215123, CN.
Link for ADAG official website?
Official Website of ADAG is: https://www.adagene.com
How do I contact ADAG?
How many shares of ADAG are traded daily?
ADAG stock volume for the day was 55682.00 shares. The average number of ADAG shares traded daily for last 3 months was 15.64 Thousands.
What is the market cap of ADAG currently?
The market value of ADAG currently stands at $75.69 Million with its latest stock price at $1.75 and N/A of its shares outstanding.